跳至主要内容
临床试验/NCT01558505
NCT01558505已完成4 期

Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation: the DEBATE-BTK Study

Leonardo Bolognese, MD2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
142
试验地点
2
主要终点
angiographic binary restenosis

研究概览

简要总结

Drug-eluting balloon showed positive results in terms of restenosis reduction in peripheral intervention (PTA). The aim of the study is to investigate in a randomized fashion the efficacy and safety of Paclitaxel-eluting balloon (PEB) (In.Pact Amphirion, Invatec, Brescia, Italy) versus non drug-eluting balloon (NEB) (Amphirion deep, Invatec, Brescia, Italy) in diabetic patients with Critical Limb Ischemia (CLI) undergoing PTA of below-the-knee (BTK) vessels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age>18 years
  • angiographic stenosis>50% or occlusion of one below-knee vessel

排除标准

  • allergy to Paclitaxel
  • contraindication for combined antiplatelet treatment
  • life expectancy <1 year
  • hypersensitivity or contraindication to one of the study drugs
  • lack of consent
  • need for amputation

结局指标

主要结局

angiographic binary restenosis

时间窗: 12 months

incidence of binary restenosis

次要结局

  • target lesion revascularization(24 months)
  • major amputation(24 motnhs)
  • vessel reocclusion(24 months)

研究者

发起方
Leonardo Bolognese, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Leonardo Bolognese, MD

Director

Ospedale San Donato

研究点 (2)

Loading locations...

相似试验

Drug Eluting Balloon in peripherAl inTErvention For... | 临床试验